Claudia Morris

Patient-Oriented Research in Arginine Deficiency Syndromes

National Center for Complementary and Integrative Health · K24

Contact PI · $1.5M · Emory University

1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)

National Heart, Lung, and Blood Institute · UH3

Contact PI · $6.9M · Emory University

1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)

National Heart, Lung, and Blood Institute · UG3

Contact PI · $1.5M · Emory University

Phase 2 RCT of Arginine Therapy for Pediatric SCD Pain IND #66,943 1/18/13 Active

Food and Drug Administration · R01

Contact PI · $1.6M · Emory University

Role of Omega-DEK in Childhood Apraxia of Speech

Principal investigator · Not yet recruiting · Phase 2

Claudia R. Morris

Arginine Replacement Therapy in COVID-19

Principal investigator · Recruiting · Phase 2

Emory University

Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial

Principal investigator · Completed · Phase 3

Claudia R. Morris

Arginine Therapy for Sickle Cell Disease Pain

Principal investigator · Completed · Phase 2

Emory University